Health Care Equipment & Services
Rash of Bad Headlines Isn't the Problem for Alphabet
Despite stories of questionable use of health care data, my concern with GOOGL is technical: We need a retest of $1,250 to $1,275 before we can move significantly higher.
InMode Has Tripled Since Its IPO: Here's How to Play It Now
Let's check out the charts of this medical technologies company.
That's It for Fitbit As I Take the Money and Run
Let others wait and see if someone comes in with a better offer than Alphabet's bid for Fitbit; this value investor is taking his profit and leaving the table.
NovoCure Looks Ready to Resume Its Strong Uptrend After a Correction
Let's review the charts and indicators of NVCR.
Fitbit Shares Shape Up on Reports of Offer From Alphabet
The maker of wearable fitness devices has seen its stock sprint higher on the buyout news after languishing this summer near multi-year lows.
Medtronic Operating Toward Renewed Gains
After correction, the medical device maker could see longer-term gains to the $150-$161 area.
Edwards Lifesciences Breaks Out to a New High
If you are not already long EW or just want to add to longs you should use any minor intraday dip today or tomorrow to buy.
Intuitive Surgical's Charts Are Bullish, Here's Our Strategy for Profits
Let's review the charts and indicators of ISRG.
If Intuitive Surgical Is Going to Move, It Will Be Immediately Post-Earnings
As the robotics sector of medicine begins to mature, ISRG finds itself as one of the old guard.
Rite Aid Charts Send Wrong Signals to Investors Who Hope for a Recovery
Sellers of the drugstore chain's stock have been aggressive for months and the overall technical picture is weak.